Barrie J. Carter

Barrie J. Carter

Directeur/Membre du Conseil chez
American Society of Gene Therapy
81 ans
Health Technology
Consumer Services
Government

Profil

Barrie J.
Carter
is currently the Director at the American Society of Gene Therapy and a Member-Advisory Committee at the University of Washington.
Previously, he held positions as the Director at Opus Bio, Inc., Chief Scientific Officer & Executive VP at AmpliPhi Biosciences Corp.
from 1992 to 2008, Vice President-Vector Biology at BioMarin Pharmaceutical, Inc. from 2013 to 2018, Principal at the National Institutes of Health in 1992, Principal at the National Institute of Diabetes & Digestive & Kidney Diseases from 1982 to 1992, and was a Member-Advisory Board at Keystone Symposia.
Dr. Carter obtained his undergraduate degree from the University of Otago in 1996 and his doctorate degree from the same university in 1969.

Postes actifs de Barrie J. Carter

SociétésPosteDébut
American Society of Gene Therapy
Directeur/Membre du Conseil -
Corporate Officer/Principal 01/01/2000

Anciens postes connus de Barrie J. Carter

SociétésPosteFin
BIOMARIN PHARMACEUTICAL INC. Corporate Officer/Principal 01/12/2018
Directeur Technique/Scientifique/R&D 06/11/2008
Corporate Officer/Principal 01/01/1992
Corporate Officer/Principal 01/01/1992
Directeur/Membre du Conseil 31/10/2011
Voir l'expérience en détail de Barrie J. Carter

Formation de Barrie J. Carter

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

77

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Consumer Services

Consumer Services

Government

Government

Commercial Services

Commercial Services

American Society of Gene Therapy

  1. Bourse
  2. Insiders
  3. Barrie J. Carter